Lexeo Therapeutics LXEO
NASDAQ LXEO
$2.94 -0.06 (-2.00%)
As of: Oct 22, 2026 · 1:11 PM EDT

Lexeo Therapeutics (LXEO) Notes Payables (2023)

Updated

Lexeo Therapeutics' Notes Payables came in at $4.15 million for Q3 2023.

Analysis

Lexeo Therapeutics (LXEO) Notes Payables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.97 Bn 1,135.56 Bn 19.71 Bn
2 Johnson & Johnson 644.38 Bn 564.24 Bn 17.30 Bn
3 AbbVie 501.54 Bn 474.65 Bn 12.70 Bn
4 Merck 359.36 Bn 313.74 Bn 12.21 Bn
5 Novartis Ag 302.13 Bn 266.12 Bn 11.24 Bn
6 Astrazeneca 267.59 Bn 241.28 Bn 12.86 Bn
7 Amgen 241.49 Bn 196.89 Bn 7.24 Bn
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn
9 Pfizer 171.77 Bn 118.41 Bn 10.94 Bn
10 Lexeo Therapeutics 251.74 Mn -408.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 4.15 Mn
API Access

Lexeo Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=LXEO&period=max&api_key=YOUR_API_KEY